Association of B7-1 co-stimulation with the development of graft arterial disease: Studies using mice lacking B7-1, B7-2 or B7-1/B7-2

American Journal of Pathology

Volumn 157, Issue 2, 2000, Pages 473-484

  Furukawa, Yutaka ^a   Mandelbrot, Didier A ^b   Libby, Peter ^a   Sharpe, Arlene H ^b   Mitchell, Richard N ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD11B ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RIBONUCLEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY GRAFT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; EXPLANT; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOSTIMULATION; LONG TERM CARE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; T LYMPHOCYTE;

EID: 0033888919     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64559-2     Document Type: Article

References (48)

1. Mechanisms of allograft rejection: The roles of cytotoxic T-cells and delayed-type hypersensitivity
2. The pathogenesis of coronary arteriosclerosis ('chronic rejection') in transplanted hearts
3. Costimulation and its role in organ transplantation
4. Surface proteins involved in T cell costimulation
5. CD28/B7 costimulation: A review
6. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
7. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
8. B70 antigen is a second ligand for CTLA-4 and CD28
9. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40
10. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts
11. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4lg reduces intimal thickening in MHC class I and II incompatible mouse heart allografts
12. Coronary atherosclerosis in transplanted mouse hearts I. Time course and immunogenetic and immunopathological considerations
13. Intederon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts
14. The role of donor and recipient B7-1 (CD80) in allograft rejection
15. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma
16. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
17. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
18. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice
19. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation
20. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection
21. Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: Assessment by flow cytometry
22. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor
23. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
24. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics
25. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: Differential regulation by T helper type 1 and T helper type 2 cytokines
26. Selective induction of B7/BB-1 on interferon-gamma stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathway
27. Activated human B lymphocytes express three CTLA-4 counter-receptors that costimulate T-cell activation
28. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg
29. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection
30. Qualitative and quantitative effects of CD28/B7-mediated costimulation on naive T cells in vitro
31. B7-2 is required for the progression but not the initiation of the type 2 immune response to a gastrointestinal nematode parasite
32. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production
33. Role of costimulators in T cell differentiation: Studies using antigen-presenting cells lacking expression of CD80 or CD86
34. Reciprocal expression of co-stimulatory molecules, B7-1 and B7-2, on murine T cells following activation
35. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
36. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28
37. Cardiac allografts from IL-4 knockout recipients: Assessment of transplant arteriosclerosis and peripheral tolerance
38. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy
39. Tolerance induction by anti-CD2 plus anti-CD3 monoclonal antibodies: Evidence for an IL-4 requirement
40. Treatment with interleukin-4 prolongs allogeneic neonatal heart graft survival by inducing T helper 2 responses
41. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts
42. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice
43. Type 2 helper T cell-type cytokines and the development of 'infectious' tolerance in rat cardiac allograft recipients
44. IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection
45. IL-10 augments allograft arterial disease: Paradoxical effects of IL-10 in vivo
46. Human endothelial stimulation of allogeneic T cells via a CTLA-4 independent pathway
47. Endothelial cells as antigen-presenting cells: Role in human transplant rejection
48. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: Origin of inflammatory and vascular wall cells